Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 15 | Walsh Mark T.Director, CEO & Director | Option exercise | M | $269K 33.5K sh | Mar 16, 2026 |
| 15 | Adamson Philip B.Chief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $9,973 1,262 sh | Mar 16, 2026 traded Mar 2, 2026 |
| 15 | Pelish Henry E.Chief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $30K 306 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 15 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Option exercise | M | $4.69M 78.7K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 15 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $363K 8,303 sh | Mar 16, 2026 traded Mar 11, 2026 |
| 15 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Option exercise | M | $4.69M 78.7K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 15 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Option exercise | M | $6.70M 112.4K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 14 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Option exercise | M | — 112.4K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 14 | Tanious Jubran N.President & COO | Grant or award | A | $1.20M 153.5K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 14 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Option exercise | M | — 78.7K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 14 | Pelish Henry E.Chief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $79K 804 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 14 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Option exercise | M | — 5,191 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 14 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Option exercise | M | — 23.9K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 14 | Pelish Henry E.Chief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $170K 1,703 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 13 | Kidwell CaseyChief Administration Officer | Option exercise | M | $29K 831 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Le Pendeven YvesCFO | Option exercise | M | — 9,767 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Gill AnnSVP, Chief Accounting Officer | Option exercise | M | — 773 sh | Mar 16, 2026 traded Mar 15, 2026 |
| 13 | Brown Brandon Louis Sr.SVP, Chief Accounting Officer | Grant or award | A | — 3,836 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Perros EvangelosChief Financial Officer | Option exercise | M | — 20.6K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Wagner AdamSee remarks | Option exercise | M | — 15.7K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Nichols Brian WGroup VP & Controller | Grant or award | A | — 921 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Kozlik ChristenChief Accounting Officer | Option exercise | M | — 1,875 sh | Mar 16, 2026 traded Mar 15, 2026 |
| 13 | Parrish DeanEVP & Chief Operating Officer | Grant or award | A | — 4,795 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Hamilton DustinChief Stores Officer | Grant or award | A | — 2,445 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Weigensberg AryeSee Remarks | Option exercise | M | — 26.8K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Kelley Joseph MichaelSenior Vice President | Grant or award | A | — 6,404 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Rosen TamiDirector, Chief Development Officer | Option exercise | M | — 15.6K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Doglioli CarlosChief Financial Officer | Tax withholding | F | $45K 1,831 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 13 | Vincent George H.Executive Vice President | Grant or award | A | — 850 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Moore Kathryn ASVP, HUMAN RESOURCES | Tax withholding | F | $42K 88 sh | Mar 16, 2026 traded Mar 14, 2026 |
| 13 | O'Brien JennieSVP, Chief Accounting Officer | Grant or award | A | — 9,917 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Watson Michael JamesEVP, Head of Axos Securities | Option exercise | M | — 1,349 sh | Mar 16, 2026 traded Mar 15, 2026 |
| 13 | Hill Jesse P.Chief Financial Officer | Tax withholding | F | $2,254 394 sh | Mar 16, 2026 traded Mar 14, 2026 |
| 13 | Oddie Andrew DavidCHIEF INTERNATIONAL OFFICER | Option exercise | M | — 12.6K sh | Mar 16, 2026 traded Mar 13, 2026 |
| 13 | Brown Brandon Louis Sr.SVP, Chief Accounting Officer | Option exercise | M | — 2,557 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Fuchsen Matthew RChief Development Officer | Grant or award | A | — 2,345 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 13 | Doucet Terrence Gregory JosephSee Remarks | Tax withholding | F | $43K 12.2K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | O'Malley KathrynChief Credit Officer | Grant or award | A | — 692 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Kennerley David John ChristopherExecutive Vice President & CFO | Grant or award | A | — 3,177 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Shah HusnalChief Product Officer | Option exercise | M | — 5,426 sh | Mar 16, 2026 traded Mar 12, 2026 |